Key facts
- This page summarizes Paul Field's Form 4 filing for 60 DEGREES PHARMACEUTICALS, INC. (SXTP).
- 3 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 21 May 2024, 20:20.
Paul Field - 31 Dec 2023 Form 4 Insider Report for 60 DEGREES PHARMACEUTICALS, INC. (SXTP)
- Reporting relationship
- Director
- Issuer ticker
- SXTP
- Reported as of
- 31 Dec 2023
- Net transaction value
- +$892
- SEC form
- 4
- Accepted by SEC
- 21 May 2024, 20:20:35 UTC
- Prior SEC filing
- 11 Jul 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Paul Field
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Paul Field filed Form 4 for 60 DEGREES PHARMACEUTICALS, INC. (SXTP) on 21 May 2024.
Change
- Previous filing in this sequence was filed on 11 Jul 2023.
- Current net transaction value: +$892.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
SXTP
transaction
Common Stock
Options Exercise
- Transaction value
- $892
- Shares
- +4,000
- Change %
- +40%
- Price
- $0.2230
- Shares after
- 14,000
- Date
- 16 May 2024
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
SXTP
transaction
Derivative
Restricted Stock Units
Award
- Transaction value
- $0
- Shares
- +4,000
- Change %
- Price
- $0.000000
- Shares after
- 4,000
- Date
- 31 Dec 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 4,000
- Exercise price
- $0.000000
- Footnotes
- F2
SXTP
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -4,000
- Change %
- -50%
- Price
- $0.000000
- Shares after
- 4,000
- Date
- 16 May 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 4,000
- Exercise price
- $0.000000
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
This transaction represents the settlement of restricted stock units in shares of common stock on May 16, 2024.
Footnote F2
Paul Field was initially granted a total of 8,000 restricted stock units ("RSUs") on July 11, 2023, of which were subsequently modified effective as of December 31, 2023 to 4,000 RSUs which were fully vested as of December 31, 2023.
Footnote F3
4,000 shares underlying the RSUs were settled as of May 16, 2024. After the settlement of the shares of common stock that were underlying the 4,000 RSUs, Paul Field did not own any RSUs.